Current Hypertension Reports

, Volume 15, Issue 4, pp 281–297 | Cite as

Fructose-Containing Sugars, Blood Pressure, and Cardiometabolic Risk: A Critical Review

  • Vanessa Ha
  • Viranda H. Jayalath
  • Adrian I. Cozma
  • Arash Mirrahimi
  • Russell J. de Souza
  • John L. SievenpiperEmail author
Hypertension and the Heart (PW de Leeuw and AH Gradman, Section Editors)


Excessive fructose intake from high-fructose corn syrup (HFCS) and sucrose has been implicated as a driving force behind the increasing prevalence of obesity and its downstream cardiometabolic complications including hypertension, gout, dyslidpidemia, metabolic syndrome, diabetes, and non-alcoholic fatty liver disease (NAFLD). Most of the evidence to support these relationships draws heavily on ecological studies, animal models, and select human trials of fructose overfeeding. There are a number of biological mechanisms derived from animal models to explain these relationships, including increases in de novo lipogenesis and uric acid-mediated hypertension. Differences between animal and human physiology, along with the supraphysiologic level at which fructose is fed in these models, limit their translation to humans. Although higher level evidence from large prospective cohorts studies has shown significant positive associations comparing the highest with the lowest levels of intake of sugar-sweetened beverages (SSBs), these associations do not hold true at moderate levels of intake or when modeling total sugars and are subject to collinearity effects from related dietary and lifestyle factors. The highest level of evidence from controlled feeding trials has shown a lack of cardiometabolic harm of fructose and SSBs under energy-matched conditions at moderate levels of intake. It is only when fructose-containing sugars or SSBs are consumed at high doses or supplement diets with excess energy that a consistent signal for harm is seen. The available evidence suggests that confounding by excess energy is an important consideration in assessing the role of fructose-containing sugars and SSBs in the epidemics of hypertension and other cardiometabolic diseases.


Fructose Sugars Sugar-sweetened beverages Cardiometabolic risk Obesity Blood pressure Hypertension Uric acid Gout Dyslipidemia Non-alcoholic fatty liver disease (NAFLD) Cardiovascular risk 



Aspects of this work were funded by a Canadian Institutes of Health Research (CIHR) Knowledge Synthesis grant (funding reference number, 102078) and a research grant from the Calorie Control Council. Vanessa Ha and Adrian Cozma were supported by Province of Ontario Graduate Scholarships. Russell J de Souza was funded by a CIHR Postdoctoral Fellowship Award. None of the sponsors had a role in any aspect of the present study, including design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

Compliance with Ethics Guidelines

Conflict of Interest

Vaness Ha and Arash Mirrahimi have received research support from the CIHR.

Viranda H. Jayalath and Adrian I. Cozma declare that they have no conflict of interest.

Russell J. de Souza has received research support from CIHR, Calorie Control Council, and The Coca-Cola Company (investigator initiated, unrestricted grant). He has also served as an external resource person to the World Health Organization's (WHO) Nutrition Guidelines Advisory Group (NUGAG), and was the lead author of a systematic review and meta-analysis commissioned by the WHO of trans fatty acids and health outcomes. The WHO paid for his travel and accommodation to attend the 5th NUGAG Meeting in Hangzhou, China (4–7 March, 2013).

John L. Sievenpiper has received research support from CIHR, Calorie Control Council, The Coca-Cola Company (investigator initiated, unrestricted grant), Pulse Canada, and The International Tree Nut Council Nutrition Research & Education Foundation. He has received travel funding, speaker fees, and/or honoraria from the American Heart Association, American Society for Nutrition (ASN), National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, Canadian Diabetes Association, Calorie Control Council, Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes, International Life Sciences Institute (ILSI) North America, ILSI Brazil, Abbott Laboratories, Pulse Canada, and The Coca-Cola Company. He is on the Clinical Practice Guidelines Expert Committee for Nutrition Therapy of both the CDA and EASD, as well as the ASN writing panel for a scientific statement on the metabolic and nutritional effects of fructose, sucrose and high fructose corn syrup. His wife is an employee of Unilever Canada.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr. 2009;139(6):1228S–35S. doi: 10.3945/jn.108.098277.PubMedCrossRefGoogle Scholar
  2. 2.
    Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79(4):537–43.PubMedGoogle Scholar
  3. 3.
    Sievenpiper JL, Toronto 3D (Diet, Digestive Tract, and Disease) Knowledge Synthesis and Clinical Trials Unit. Fructose: where does the truth lie? J Am Coll Nutr. 2012;31(3):149–51.Google Scholar
  4. 4.
    Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc. 2010;110(9):1307–21. doi: 10.1016/j.jada.2010.06.008.PubMedCrossRefGoogle Scholar
  5. 5.
    Grynbaum MM. Will soda restrictions help New York win the war on obesity? BMJ. 2012;345:e6768. doi: 10.1136/bmj.e6768.PubMedCrossRefGoogle Scholar
  6. 6.
    Ontario Medical Association. Ontario’s Doctors Call for Urgent Action to Combat Obesity Epidemic. Toronto, Ontario. 2012.
  7. 7.
    Segal MS, Gollub E, Johnson RJ. Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index? Eur J Nutr. 2007;46(7):406–17. doi: 10.1007/s00394-007-0680-9.PubMedCrossRefGoogle Scholar
  8. 8.
    Sievenpiper JL, de Souza RJ, Kendall CW, Jenkins DJ. Is fructose a story of mice but not men? J Am Diet Assoc. 2011;111(2):219–20. doi: 10.1016/j.jada.2010.12.001. author reply 20–2.PubMedCrossRefGoogle Scholar
  9. 9.
    Schulze MB, Fung TT, Manson JE, Willett WC, Hu FB. Dietary patterns and changes in body weight in women. Obesity. 2006;14(8):1444–53. doi: 10.1038/oby.2006.164.PubMedCrossRefGoogle Scholar
  10. 10.
    Schulze MB, Hoffmann K, Manson JE, Willett WC, Meigs JB, Weikert C, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr. 2005;82(3):675–84. quiz 714–5.PubMedGoogle Scholar
  11. 11.
    American Diabetes Association. Executive summary: standards of medical care in diabetes--2011. Diabetes Care. 2011;34 Suppl 1:S4–S10. doi: 10.2337/dc11-S004.Google Scholar
  12. 12.
    American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114(1):82–96. doi: 10.1161/CIRCULATIONAHA.106.176158.Google Scholar
  13. 13.
    Dworatzek PD, Arcudi K, Gougeon R, Husein N, Sievenpiper JL, Williams SL. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Nutrition Therapy. Can J Diabetes. 2013;37:S45–S55.Google Scholar
  14. 14.
    Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, et al. The 2013 canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2013;29:528–42.Google Scholar
  15. 15.
    Mann JI, De Leeuw I, Hermansen K, Karamanos B, Karlström B, Katsilambros N, Riccardi G, Rivellese AA, Rizkalla S, Slama G, Toeller M, Uusitupa M, Vessby B; Diabetes and Nutrition Study Group (DNSG) of the European Association. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metabol Cardiovasc Dis. 2004;14(6):373–94.Google Scholar
  16. 16.
    Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington DC: The National Academies Press; 2005.Google Scholar
  17. 17.
    • Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120(11):1011–20. doi: 10.1161/CIRCULATIONAHA.109.192627. These guidelines represent the most recent AHA evidence-based recommendations for sugar intakes on CVD risk. Recommendations include limiting sugar intake to 100 cal per day for women and 150 cal per day for men. No specific recommendations were made for fructose intake.PubMedCrossRefGoogle Scholar
  18. 18.
    Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292–333. doi: 10.1161/CIR.0b013e3182160726.PubMedCrossRefGoogle Scholar
  19. 19.
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.Google Scholar
  20. 20.
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421.Google Scholar
  21. 21.
    U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, December 2010.Google Scholar
  22. 22.
    WHO Study Group. Diet, nutrition, and the prevention of chronic diseases. Geneva, World Health Organization, 1990 (WHO Technical Report Series, No. 797).Google Scholar
  23. 23.
    Skanes AC, Healey JS, Cairns JA, Dorian P, Gillis AM, McMurtry MS, et al. Focused 2012 update of the Canadian cardiovascular society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol. 2012;28(2):125–36. doi: 10.1016/j.cjca.2012.01.021.PubMedCrossRefGoogle Scholar
  24. 24.
    Basu S, Yoffe P, Hills N, Lustig RH. The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One. 2013;8(2):e57873. doi: 10.1371/journal.pone.0057873.PubMedCrossRefGoogle Scholar
  25. 25.
    Goran MI, Ulijaszek SJ, Ventura EE. High fructose corn syrup and diabetes prevalence: a global perspective. Global Publ Health. 2013;8(1):55–64. doi: 10.1080/17441692.2012.736257.CrossRefGoogle Scholar
  26. 26.
    HealthCanada. Canadian Community Health Survey, Cycle 2.2, Nutrition. 2004.Google Scholar
  27. 27.
    Barclay AW, Brand-Miller J. The Australian paradox: a substantial decline in sugars intake over the same timeframe that overweight and obesity have increased. Nutrients. 2011;3(4):491–504. doi: 10.3390/nu3040491.PubMedCrossRefGoogle Scholar
  28. 28.
    Welsh JA, Sharma AJ, Grellinger L, Vos MB. Consumption of added sugars is decreasing in the United States. Am J Clin Nutr. 2011;94(3):726–34. doi: 10.3945/ajcn.111.018366.PubMedCrossRefGoogle Scholar
  29. 29.
    Ruxton CH, Gardner EJ, McNulty HM. Is sugar consumption detrimental to health? A review of the evidence 1995–2006. Crit Rev Food Sci Nutr. 2010;50(1):1–19. doi: 10.1080/10408390802248569.PubMedCrossRefGoogle Scholar
  30. 30.
    Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41. doi: 10.1001/jama.2009.2014.PubMedCrossRefGoogle Scholar
  31. 31.
    StatisticsCanada. Food Statistics. 2011.Google Scholar
  32. 32.
    Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65(4 Suppl):1220S–8S. discussion 9S-31S.PubMedGoogle Scholar
  33. 33.
    •• Cohen L, Curhan G, Forman J. Association of sweetened beverage intake with incident hypertension. J Gen Intern Med. 2012;27(9):1127–34. doi: 10.1007/s11606-012-2069-6. This study consisted of three large prospective cohorts (Nurse Health Studies [NHS] I and II, and Health Professionals Follow-up Study [HPFS]) that assessed the association between the intake of sugar-sweetened beverages (SSBs) as well as fructose by source (SSBs vs fruits and vegetables) and hypertension risk. Individuals with higher intake of fructose consumption were more likely to have greater intakes of SSBs and poorer dietary patterns. In the multivariate adjusted models, a significant increased risk of developing hypertension was found when comparing the highest (≥ 1 serving per day) to the lowest (< 1 serving per month) quantile of intake of SSBs in NHS I and II but not HPFS. Only NHS I found a significantly greater risk of developing hypertension (hazard ratio, 1.20) when the highest intake was compared to the lowest intake of fructose from SSBs. No significant greater risk of developing hypertension was found when the highest fructose intake from fruits and vegetables was compared to the lowest.
  34. 34.
    Fung TT, Rimm EB, Spiegelman D, Rifai N, Tofler GH, Willett WC, et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr. 2001;73(1):61–7.PubMedGoogle Scholar
  35. 35.
    Fung TT, Stampfer MJ, Manson JE, Rexrode KM, Willett WC, Hu FB. Prospective study of major dietary patterns and stroke risk in women. Stroke. 2004;35(9):2014–9. doi: 10.1161/01.STR.0000135762.89154.92.PubMedCrossRefGoogle Scholar
  36. 36.
    Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987;10(5):512–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007;86(4):899–906.PubMedGoogle Scholar
  38. 38.
    Tran LT, Yuen VG, McNeill JH. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem. 2009;332(1–2):145–59. doi: 10.1007/s11010-009-0184-4.PubMedCrossRefGoogle Scholar
  39. 39.
    Lewis GF, Uffelman K, Naples M, Szeto L, Haidari M, Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology. 2005;146(1):247–55. doi: 10.1210/en.2004-1143.PubMedCrossRefGoogle Scholar
  40. 40.
    Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, Le-Tien H, Fantus IG, Lewis GF, et al. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem. 2002;277(1):793–803. doi: 10.1074/jbc.M106737200.PubMedCrossRefGoogle Scholar
  41. 41.
    Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76(5):911–22.PubMedGoogle Scholar
  42. 42.
    Sun SZ, Empie MW. Fructose metabolism in humans - what isotopic tracer studies tell us. Nutr Metabol. 2012;9(1):89. doi: 10.1186/1743-7075-9-89.CrossRefGoogle Scholar
  43. 43.
    Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90(1):23–46. doi: 10.1152/physrev.00019.2009.PubMedCrossRefGoogle Scholar
  44. 44.
    •• Ha V, Sievenpiper JL, de Souza RJ, Chiavaroli L, Wang DD, Cozma AI, et al. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension. 2012;59(4):787–95. doi: 10.1161/HYPERTENSIONAHA.111.182311. This is the first systematic review and meta-analysis examining the effects of fructose on blood pressure under isocaloric (fructose exchanged for another carbohydrate) and hypercaloric (fructose supplemented on top of a control diet providing excess energy relative to the control diet alone) conditions. Fructose under isocaloric conditions resulted in a significant reduction in DBP (−1.54 mmHg; p = 0.01) and MAP (−1.16 mmHg; p = 0.02), but no significant effect on SBP (−1.10 mmHg; p = 0.16). No significant effect of fructose was seen for MAP under hypercaloric conditions (+18-25 % of energy).PubMedCrossRefGoogle Scholar
  45. 45.
    Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. New Engl J Med. 2009;360(9):859–73. doi: 10.1056/NEJMoa0804748.PubMedCrossRefGoogle Scholar
  46. 46.
    Peterson DB, Lambert J, Gerring S, Darling P, Carter RD, Jelfs R, et al. Sucrose in the diet of diabetic patients–just another carbohydrate? Diabetologia. 1986;29(4):216–20.PubMedCrossRefGoogle Scholar
  47. 47.
    Poppitt SD, Keogh GF, Prentice AM, Williams DE, Sonnemans HM, Valk EE, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr. 2002;75(1):11–20.PubMedGoogle Scholar
  48. 48.
    Claesson AL, Holm G, Ernersson A, Lindstrom T, Nystrom FH. Two weeks of overfeeding with candy, but not peanuts, increases insulin levels and body weight. Scand J Clin Lab Investig. 2009;69(5):598–605. doi: 10.1080/00365510902912754.CrossRefGoogle Scholar
  49. 49.
    Raben A, Vasilaras TH, Moller AC, Astrup A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr. 2002;76(4):721–9.PubMedGoogle Scholar
  50. 50.
    Maersk M, Belza A, Stodkilde-Jorgensen H, Ringgaard S, Chabanova E, Thomsen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr. 2012;95(2):283–9. doi: 10.3945/ajcn.111.022533.PubMedCrossRefGoogle Scholar
  51. 51.
    Adamsson V, Reumark A, Fredriksson IB, Hammarstrom E, Vessby B, Johansson G, et al. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET). J Intern Med. 2011;269(2):150–9. doi: 10.1111/j.1365-2796.2010.02290.x.PubMedCrossRefGoogle Scholar
  52. 52.
    Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-sodium collaborative research group. New Engl J Med. 2001;344(1):3–10. doi: 10.1056/NEJM200101043440101.PubMedCrossRefGoogle Scholar
  53. 53.
    Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, Engberink MF, Willett WC, et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose–response meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011;93(1):158–71. doi: 10.3945/ajcn.2010.29866.PubMedCrossRefGoogle Scholar
  54. 54.
    Tate DF, Turner-McGrievy G, Lyons E, Stevens J, Erickson K, Polzien K, et al. Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. Am J Clin Nutr. 2012;95(3):555–63. doi: 10.3945/ajcn.111.026278.PubMedCrossRefGoogle Scholar
  55. 55.
    Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293(1):43–53. doi: 10.1001/jama.293.1.43.PubMedCrossRefGoogle Scholar
  56. 56.
    •• Forman JP, Choi H, Curhan GC. Fructose and vitamin C intake do not influence risk for developing hypertension. JASN. 2009;20(4):863–71. doi: 10.1681/ASN.2008050473. This study assessed the association between total fructose intake and hypertension risk in three large and independent Harvard prospective cohorts (Nurse Health Studies [NHS] I and II, and Health Professionals Follow-Up [HPFS]). In the multivariate adjusted models, none of the studies showed a significant increased risk for developing hypertension when comparing the highest (14.3, 14.3, 13.9 % E in NHS I and II, and HPFS, respectively) with the lowest (6.0, 5.7, 5.7 % E in NHS I and II, and HPFS, respectively) quantile intakes.
  57. 57.
    Fung TT, Hu FB, Pereira MA, Liu S, Stampfer MJ, Colditz GA, et al. Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr. 2002;76(3):535–40.PubMedGoogle Scholar
  58. 58.
    Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. New Engl J Med. 2011;364(25):2392–404. doi: 10.1056/NEJMoa1014296.PubMedCrossRefGoogle Scholar
  59. 59.
    Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142(7):1304–13. doi: 10.3945/jn.111.155325.PubMedCrossRefGoogle Scholar
  60. 60.
    Jenkins DJ, Srichaikul K, Kendall CW, Sievenpiper JL, Abdulnour S, Mirrahimi A, et al. The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia. 2011;54(2):271–9. doi: 10.1007/s00125-010-1927-1.PubMedCrossRefGoogle Scholar
  61. 61.
    Madero M, Arriaga JC, Jalal D, Rivard C, McFann K, Perez-Mendez O, et al. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metab Clin Exp. 2011;60(11):1551–9. doi: 10.1016/j.metabol.2011.04.001.PubMedCrossRefGoogle Scholar
  62. 62.
    • Duffey KJ, Gordon-Larsen P, Steffen LM, Jacobs Jr DR, Popkin BM. Drinking caloric beverages increases the risk of adverse cardiometabolic outcomes in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2010;92(4):954–9. doi: 10.3945/ajcn.2010.29478. This analysis of the CARDIA study, a prospective cohort study involving 5,115 individuals, assessed the association between the intakes of different beverages including sugar-sweetened beverages and the risk of developing features of the metabolic syndrome. Higher consumption of SSBs was significantly associated with higher risk of high waist circumference (adjusted relative risk, 1.09), high LDL cholesterol (adjusted relative risk, 1.18), high triglycerides (adj-RR: 1.06), and hypertension (adjusted relative risk, 1.06).PubMedCrossRefGoogle Scholar
  63. 63.
    Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006;84(2):274–88.PubMedGoogle Scholar
  64. 64.
    Halton TL, Willett WC, Liu S, Manson JE, Stampfer MJ, Hu FB. Potato and french fry consumption and risk of type 2 diabetes in women. Am J Clin Nutr. 2006;83(2):284–90.PubMedGoogle Scholar
  65. 65.
    Pan A, Sun Q, Bernstein AM, Schulze MB, Manson JE, Willett WC, et al. Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr. 2011;94(4):1088–96. doi: 10.3945/ajcn.111.018978.PubMedCrossRefGoogle Scholar
  66. 66.
    Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72(4):912–21.PubMedGoogle Scholar
  67. 67.
    • Wang DD, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Cozma AI, et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr. 2012;142(5):916–23. doi: 10.3945/jn.111.151951. This is the first systematic review and meta-analysis examining the effects of fructose on uric acid under isocaloric (fructose exchanged for another carbohydrate under energy matched conditions) and hypercaloric (fructose supplemented on top of a control diet providing excess energy relative to the control diet alone) conditions. Fructose under isocaloric conditions did not significantly effect uric acid in pre-diabetes/diabetes (−4.09 μmol/L, p = 0.68) and non-diabetes (1.28 μmol/L, p = 0.75). There was a significant effect of fructose under hypercaloric conditions on uric acid in non-diabetes (31.0 μmol/L, p = 0.05). The absence of an effect under isocaloric conditions suggests that the uric acid increasing effect under hypercaloric conditions appears to be more attributable to the excess energy than fructose.PubMedCrossRefGoogle Scholar
  68. 68.
    Livesey G. Fructose ingestion: dose-dependent responses in health research. J Nutr. 2009;139(6):1246S–52S. doi: 10.3945/jn.108.097949.PubMedCrossRefGoogle Scholar
  69. 69.
    Bantle JP, Laine DC, Thomas JW. Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA. 1986;256(23):3241–6.PubMedCrossRefGoogle Scholar
  70. 70.
    Blayo A, Fontvieille AM, Rizkalla S, Bruzzo F, Slama G. Metabolic effects of daily intake of sucrose or fructose by diabetics for one year. Médecine et Nutrition. 1990;26(1):11–4.Google Scholar
  71. 71.
    Sun SZ, Flickinger BD, Williamson-Hughes PS, Empie MW. Lack of association between dietary fructose and hyperuricemia risk in adults. Nutr Metabol. 2010;7:16. doi: 10.1186/1743-7075-7-16.CrossRefGoogle Scholar
  72. 72.
    Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 2008;336(7639):309–12. doi: 10.1136/bmj.39449.819271.BE.PubMedCrossRefGoogle Scholar
  73. 73.
    Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in women. JAMA. 2010;304(20):2270–8. doi: 10.1001/jama.2010.1638.PubMedCrossRefGoogle Scholar
  74. 74.
    Bomback AS, Derebail VK, Shoham DA, Anderson CA, Steffen LM, Rosamond WD, et al. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int. 2010;77(7):609–16. doi: 10.1038/ki.2009.500.PubMedCrossRefGoogle Scholar
  75. 75.
    Sievenpiper JL, Carleton AJ, Chatha S, Jiang HY, de Souza RJ, Beyene J, et al. Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care. 2009;32(10):1930–7. doi: 10.2337/dc09-0619.PubMedCrossRefGoogle Scholar
  76. 76.
    Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr. 2008;88(5):1419–37.PubMedGoogle Scholar
  77. 77.
    Sievenpiper JL, Chiavaroli L, de Souza RJ, Mirrahimi A, Cozma AI, Ha V, et al. 'Catalytic' doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials. Br J Nutr. 2012;108(3):418–23. doi: 10.1017/S000711451200013X.PubMedCrossRefGoogle Scholar
  78. 78.
    Coulston AM, Hollenbeck CB, Donner CC, Williams R, Chiou YA, Reaven GM. Metabolic effects of added dietary sucrose in individuals with noninsulin-dependent diabetes mellitus (NIDDM). Metab Clin Exp. 1985;34(10):962–6.PubMedCrossRefGoogle Scholar
  79. 79.
    Roberts AM. Effects of a sucrose-free diet on the serum-lipid levels of men in Antarctica. Lancet. 1973;1(7814):1201–4.PubMedCrossRefGoogle Scholar
  80. 80.
    Cooper PL, Wahlqvist ML, Simpson RW. Sucrose versus saccharin as an added sweetener in non-insulin-dependent diabetes: short- and medium-term metabolic effects. Diabet Med. 1988;5(7):676–80.PubMedCrossRefGoogle Scholar
  81. 81.
    Jellish WS, Emanuele MA, Abraira C. Graded sucrose/carbohydrate diets in overtly hypertriglyceridemic diabetic patients. Am J Med. 1984;77(6):1015–22.PubMedCrossRefGoogle Scholar
  82. 82.
    Huttunen JK, Mäkinen KK, Scheinin A. Turku Sugar Studies XI. Acta Odontol Scand. 1976;33 Suppl 70:239–45.Google Scholar
  83. 83.
    Kaufmann NA, Poznanski R, Blondheim SH, Stein Y. Effect of fructose, glucsoe, sucrose, and starch on serum lipids in carbohydrate induced hypertriglyceridemia and in normal subjects. Isr J Med Sci. 1966;2:715–26.PubMedGoogle Scholar
  84. 84.
    Mann JI, Hendricks DA, Truswell AS, Manning E. Effects on serum-lipids in normal men of reducing dietary sucrose or starch for five months. Lancet. 1970;1(7652):870–2.PubMedCrossRefGoogle Scholar
  85. 85.
    Nikkila EA, Kekki M. Effects of dietary fructose and sucrose on plasma triglyceride metabolism in patients with endogenous hypertriglyceridemia. Acta Med Scand Suppl. 1972;542:221–7.PubMedGoogle Scholar
  86. 86.
    Saris WH, Astrup A, Prentice AM, Zunft HJ, Formiguera X, Verboeket-van de Venne WP, et al. Randomized controlled trial of changes in dietary carbohydrate/fat ratio and simple vs complex carbohydrates on body weight and blood lipids: the CARMEN study. The Carbohydrate Ratio Management in European National diets. Int J Obes. 2000;24(10):1310–8.Google Scholar
  87. 87.
    Smith JB, Niven BE, Mann JI. The effect of reduced extrinsic sucrose intake on plasma triglyceride levels. Eur J Clin Nutr. 1996;50(8):498–504.PubMedGoogle Scholar
  88. 88.
    Chantelau EA, Gösseringer G, Sonnenberg GE, Berger M. Moderate intake of sucrose does not impair metabolic control in pump-treated diabetic out-patients. Diabetologia. 1985;28:204–7.PubMedCrossRefGoogle Scholar
  89. 89.
    Colagiuri S, Miller JJ, Edwards RA. Metabolic effects of adding sucrose and aspartame to the diet of subjects with non- insulin-dependent diabetes mellitus. Am J Clin Nutr. 1989;50:474–8.PubMedGoogle Scholar
  90. 90.
    •• Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, Beyene J, et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med. 2012;156(4):291–304. doi: 10.1059/0003-4819-156-4-201202210-00007. This systematic review and meta-analysis examined the effects of fructose on body weight under isocaloric (fructose exchanged for another carbohydrate under energy matched conditions) and hypercaloric (fructose supplemented on top of a control diet providing excess energy relative to the control diet alone) conditions. Fructose under isocaloric conditions did not significantly change body weight (−0.14 kg; p = 0.21). There was a significant body-weight increasing effect of fructose under hypercaloric conditions (0.53 kg; p < 0.001). The absence of an effect under isocaloric conditions suggests that the body weight increasing effect under hypercaloric conditions appears to be more attributable to the excess energy than fructose.PubMedCrossRefGoogle Scholar
  91. 91.
    Beck-Nielsen H, Pedersen O, Lindskov HO. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr. 1980;33:273–8.PubMedGoogle Scholar
  92. 92.
    Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322–34. doi: 10.1172/JCI37385.PubMedCrossRefGoogle Scholar
  93. 93.
    Stanhope KL, Griffen SC, Bremer AA, Vink RG, Schaefer EJ, Nakajima K, Schwarz JM, et al. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am J Clin Nutr. 2011;94:112–9. doi: 10.3945/ajcn.110.002246.PubMedCrossRefGoogle Scholar
  94. 94.
    •• Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. British Medical Journal. 2013;346:e7492. doi: 10.1136/bmj.e7492. This systematic review and meta-analysis examined the effects of dietary sugar intake on body weight in 31 randomized trials and 40 prospective cohort studies. Aggregate analyses of the randomized trials showed that reduced intake of sugars resulted in significant weight loss (−0.80 kg; p < 0.001), while increased intake of sugars resulted in significant weight gain (0.75 kg; p = 0.001) in adults. Isocaloric exchange of sugars with other carbohydrates, however, showed no change in body weight (0.04 kg; p = 0.30). Intakes of sugar-sweetened beverages were associated with an increased risk of being overweight or obese (odds ratio, 1.55), comparing the highest with the lowest intakes in aggregate analyses of the prospective cohort studies. The absence of an effect of sugars in isocaloric exchange with other carbohydrates on body weight suggests that sugars are a determinant of body weight in so far as they supplement or displace energy.CrossRefGoogle Scholar
  95. 95.
    Mattes RD, Shikany JM, Kaiser KA, Allison DB. Nutritively sweetened beverage consumption and body weight: a systematic review and meta-analysis of randomized experiments. Obes Rev. 2011;12(5):346–65. doi: 10.1111/j.1467-789X.2010.00755.x.PubMedCrossRefGoogle Scholar
  96. 96.
    de Ruyter JC, Olthof MR, Seidell JC, Katan MB. A trial of sugar-free or sugar-sweetened beverages and body weight in children. New Engl J Med. 2012;367(15):1397–406. doi: 10.1056/NEJMoa1203034.PubMedCrossRefGoogle Scholar
  97. 97.
    Ebbeling CB, Feldman HA, Chomitz VR, Antonelli TA, Gortmaker SL, Osganian SK, Ludwig DS. A randomized trial of sugar-sweetened beverages and adolescent body weight. New Engl J Med. 2012;367:1407–16. doi: 10.1056/NEJMoa1203388.Google Scholar
  98. 98.
    Horton TJ, Drougas H, Brachey A, Reed GW, Peters JC, Hill JO. Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am J Clin Nutr. 1995;62(1):19–29.PubMedGoogle Scholar
  99. 99.
    Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292(8):927–34. doi: 10.1001/jama.292.8.927.PubMedCrossRefGoogle Scholar
  100. 100.
    Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34(3):362–6.PubMedGoogle Scholar
  101. 101.
    Cozma AI, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Wang DD, et al. Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care. 2012;35(7):1611–20. doi: 10.2337/dc12-0073.PubMedCrossRefGoogle Scholar
  102. 102.
    Hawkins M, Gabriely I, Wozniak R, Vilcu C, Shamoon H, Rossetti L. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. Diabetes. 2002;51(3):606–14.PubMedCrossRefGoogle Scholar
  103. 103.
    Malerbi DA, Paiva ES, Duarte AL, Wajchenberg BL. Metabolic effects of dietary sucrose and fructose in type II diabetic subjects. Diabetes Care. 1996;19:1249–56.PubMedCrossRefGoogle Scholar
  104. 104.
    de Souza RJ, Bray GA, Carey VJ, Hall KD, LeBoff MS, Loria CM, et al. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr. 2012;95(3):614–25. doi: 10.3945/ajcn.111.026328.PubMedCrossRefGoogle Scholar
  105. 105.
    Hodge AM, English DR, O'Dea K, Giles GG. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care. 2004;27(11):2701–6.PubMedCrossRefGoogle Scholar
  106. 106.
    Meyer KA, Kushi LH, Jacobs Jr DR, Slavin J, Sellers TA, Folsom AR. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 2000;71(4):921–30.PubMedGoogle Scholar
  107. 107.
    Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in women. Am J Clin Nutr. 1992;55(5):1018–23.PubMedGoogle Scholar
  108. 108.
    Janket SJ, Manson JE, Sesso H, Buring JE, Liu S. A prospective study of sugar intake and risk of type 2 diabetes in women. Diabetes Care. 2003;26(4):1008–15.PubMedCrossRefGoogle Scholar
  109. 109.
    Montonen J, Jarvinen R, Knekt P, Heliovaara M, Reunanen A. Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr. 2007;137(6):1447–54.PubMedGoogle Scholar
  110. 110.
    Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33(11):2477–83. doi: 10.2337/dc10-1079.PubMedCrossRefGoogle Scholar
  111. 111.
    Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450–5.PubMedCrossRefGoogle Scholar
  112. 112.
    Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Haring HU, et al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr. 2011;106(1):79–86. doi: 10.1017/S000711451000574X.PubMedCrossRefGoogle Scholar
  113. 113.
    Aeberli I, Gerber PA, Hochuli M, Kohler S, Haile SR, Gouni-Berthold I, Berthold HK, et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr. 2011;94:479–85. doi: 10.3945/ajcn.111.013540.Google Scholar
  114. 114.
    Ngo Sock ET, Le KA, Ith M, Kreis R, Boesch C, Tappy L. Effects of a hort-term overfeeding with fructose or glucose in healthy young males. Br J Nutr. 2010;103:939–43.PubMedCrossRefGoogle Scholar
  115. 115.
    Le KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr. 2006;84(6):1374–9.PubMedGoogle Scholar
  116. 116.
    Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89(6):1760–5. doi: 10.3945/ajcn.2008.27336.PubMedCrossRefGoogle Scholar
  117. 117.
    Sobrecases H, Le KA, Bortolotti M, Schneiter P, Ith M, Kreis R, et al. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metabol. 2010;36(3):244–6. doi: 10.1016/j.diabet.2010.03.003.CrossRefGoogle Scholar
  118. 118.
    Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48(6):993–9. doi: 10.1016/j.jhep.2008.02.011.PubMedCrossRefGoogle Scholar
  119. 119.
    Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A, et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology. 2012;56(3):952–60. doi: 10.1002/hep.25741.PubMedCrossRefGoogle Scholar
  120. 120.
    Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol. 2009;51(5):918–24. doi: 10.1016/j.jhep.2009.05.033.PubMedCrossRefGoogle Scholar
  121. 121.
    Mouzaki M, Allard JP. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol. 2012;46(6):457–67. doi: 10.1097/MCG.0b013e31824cf51e.PubMedCrossRefGoogle Scholar
  122. 122.
    Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr. 2000;71(6):1455–61.PubMedGoogle Scholar
  123. 123.
    van Dam RM, Visscher AW, Feskens EJ, Verhoef P, Kromhout D. Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study. Eur J Clin Nutr. 2000;54(9):726–31.PubMedCrossRefGoogle Scholar
  124. 124.
    • Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr. 2009;89(4):1037–42. doi: 10.3945/ajcn.2008.27140. This Nurses’ Health Study (1980–2004) of 88250 women assessed the association between sugar-sweetened beverage intake and the risk of developing coronary heart disease (CHD). In their multivariate analysis, intakes of SSBs were significantly associated with developing CHD (relative risk, 1.35), comparing the highest (≥ 2 servings per day) with the lowest (never) intakes.PubMedCrossRefGoogle Scholar
  125. 125.
    • Bernstein AM, de Koning L, Flint AJ, Rexrode KM, Willett WC. Soda consumption and the risk of stroke in men and women. Am J Clin Nutr. 2012;95(5):1190–9. doi: 10.3945/ajcn.111.030205. This Nurse Health Studies of 84,085 women followed for 28 years assessed the relation of sugar-sweetened beverage intakes with the risk of stroke. The association of total stroke for ≥ 1 serving of sugar-sweetened beverages per day compared with none was non-significant (relative risk, 1.16).PubMedCrossRefGoogle Scholar
  126. 126.
    • Eshak ES, Iso H, Kokubo Y, Saito I, Yamagishi K, Inoue M, et al. Soft drink intake in relation to incident ischemic heart disease, stroke, and stroke subtypes in Japanese men and women: the Japan Public Health Centre-based study cohort I. Am J Clin Nutr. 2012;96(6):1390–7. doi: 10.3945/ajcn.112.037903. This Japanese prospective cohort study of 39,786 individuals with a 18-year follow-up period assessed the risk of developing cardiovascular disease with soft drink intakes. Soft drink intake was positively associated with risk of total stroke for women (adjusted hazard ratio, 1.21; p = 0.02) in those with the highest intake (≥ 1 serving per day) compared with those with the lowest intake (never or rarely). No significant association was found for men.PubMedCrossRefGoogle Scholar
  127. 127.
    Mirrahimi A, de Souza RJ, Chiavaroli L, Sievenpiper JL, Beyene J, Hanley AJ, et al. Associations of glycemic index and load with coronary heart disease events: a systematic review and meta-analysis of prospective cohorts. J Am Heart Assoc. 2012;1(5):e000752. doi: 10.1161/JAHA.112.000752.PubMedCrossRefGoogle Scholar
  128. 128.
    Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. New Engl J Med. 1989;321(10):641–6. doi: 10.1056/NEJM198909073211004.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Vanessa Ha
    • 1
    • 2
  • Viranda H. Jayalath
    • 1
    • 2
  • Adrian I. Cozma
    • 1
    • 2
  • Arash Mirrahimi
    • 1
  • Russell J. de Souza
    • 1
    • 3
  • John L. Sievenpiper
    • 1
    • 4
    • 5
    Email author
  1. 1.Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification CentreSt. Michael’s HospitalTorontoCanada
  2. 2.Department of Nutritional Sciences, Faculty of MedicineUniversity of TorontoTorontoCanada
  3. 3.Department of Clinical Epidemiology and BiostatisticsMcMaster UniversityHamiltonCanada
  4. 4.Department of Pathology and Molecular Medicine, Faculty of Health SciencesMcMaster UniversityHamiltonCanada
  5. 5.Knowledge Synthesis Lead, Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification CenterSt. Michael’s HospitalTorontoCanada

Personalised recommendations